Hangzhou Tigermed Consulting (03347) spent 208 million yuan on June 15 to repurchase 5.31 million A-shares.
Tiger Pharmaceuticals (03347) announced that on June 15, 2026, the company will spend RMB 208 million to repurchase 5.3131 million A shares, with a repurchase price of RMB 38.84-39.58 per share.
Hangzhou Tigermed Consulting (03347) released an announcement on June 15, 2026, stating that the company will spend RMB 208 million to repurchase 5.31 million A shares, with a repurchase price of RMB 38.84-39.58 per share.
Related Articles
From the frenzy on the dark market to the hard work on entering the main market: CREALITY (03388) is holding its ground in the horizontal market.
Hong Kong student dormitory operator Student Living EduVation (SDLV.US) raises fundraising target to $31 million IPO price $4-6 per share.
One picture understanding the Hong Kong Stock Exchange IPO of LB Pharmaceuticals (09637)
From the frenzy on the dark market to the hard work on entering the main market: CREALITY (03388) is holding its ground in the horizontal market.
Hong Kong student dormitory operator Student Living EduVation (SDLV.US) raises fundraising target to $31 million IPO price $4-6 per share.
One picture understanding the Hong Kong Stock Exchange IPO of LB Pharmaceuticals (09637)
RECOMMEND
